BMRN

#862
BioMarin Pharmaceuticals Inc
55.37 USD
+0.89%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
55.28
55.44
Intervallo Annuale
50.76
66.28
Variazione giornaliera
+0.89%
Variazione Mensile
-2.29%
Variazione di 6 mesi
+5.79%
Variazione Annuale
-7.13%
Chiusura Precedente
54.88
Apertura
55.32
Bid
Ask
Minimo
55.28
High
55.44
Volume
211
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 10.65 B
  • Employee 3 221
  • Founded N/A
  • CEO Alexander Hardy
  • Website www.biomarin.com
  • Headquarter Delaware, United States
  • FIGI BBG000CZWZ05
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
33.02
Rapporto prezzo/fatturato
3.64

BioMarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria. Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials.

Notizie